Company StemCells Inc Nasdaq
Equities
US85857R2040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 88-08-01 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 21-12-31 |
Chief Tech/Sci/R&D Officer | - | 11-30 | |
Simon Sharon
CTO | Chief Tech/Sci/R&D Officer | 64 | 18-04-04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 16-11-27 |
Director/Board Member | 66 | 17-12-11 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 20-07-31 |
Harel Gadot
CEO | Chief Executive Officer | 52 | 88-08-01 |
Yossi Bornstein
FOU | Founder | 66 | 88-08-01 |
Martin Madden
BRD | Director/Board Member | 64 | 17-02-05 |
Director/Board Member | 62 | 20-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,398,964 | 14,156,936 ( 98.32 %) | 0 | 98.32 % |
Company contact information
Microbot Medical, Inc.
288 Grove Street Suite 388
02184, Braintree
+781 875 3605
http://microbotmedical.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- MBOT Stock
- Stock
- Company StemCells Inc